Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice

BACKGROUND: Treatment of Escherichia coli O157:H7 infections with antimicrobial agents is controversial due to an association with potentially fatal sequelae. The production of Shiga toxins is believed to be central to the pathogenesis of this organism. Therefore, decreasing the expression of these...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahal, Elias A, Kazzi, Natalie, Sabra, Ahmad, Abdelnoor, Alexander M, Matar, Ghassan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180354/
https://www.ncbi.nlm.nih.gov/pubmed/21906403
http://dx.doi.org/10.1186/1476-0711-10-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180354/
https://www.ncbi.nlm.nih.gov/pubmed/21906403
http://dx.doi.org/10.1186/1476-0711-10-34

Ejemplares similares